MORE VIDEOS
Udforsk mere
Brystkræft

Næste

Automatisk afspilning
Transplantation for AL amyloidosis is associated with low mortality rates at a center in Brazil
00:01:23
Transplantation for AL amyloidosis is associated with low mortality rates at a center in Brazil
0 Visninger . 06/06/25 administrator
Phillip Hawkins - Amyloidosis and Benefits of Transplantation
00:14:54
Phillip Hawkins - Amyloidosis and Benefits of Transplantation
5 Visninger . 11/23/23 administrator
Outcomes of renal transplantation in patients with AL amyloidosis
00:01:20
Outcomes of renal transplantation in patients with AL amyloidosis
6 Visninger . 11/23/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 Visninger . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 Visninger . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
3 Visninger . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 Visninger . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
3 Visninger . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visninger . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 Visninger . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 Visninger . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 Visninger . 08/09/23 administrator
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
00:04:47
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
4 Visninger . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 Visninger . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
2 Visninger . 08/09/23 administrator
Clonal evolution in patients with CTCL
00:02:24
Clonal evolution in patients with CTCL
4 Visninger . 08/09/23 administrator
RESMAIN: HDAC inhibitor resminostat for CTCL
00:01:23
RESMAIN: HDAC inhibitor resminostat for CTCL
3 Visninger . 08/09/23 administrator
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
00:13:18
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
2 Visninger . 08/09/23 administrator
Unmet needs and upcoming therapies in CTCL
00:03:34
Unmet needs and upcoming therapies in CTCL
2 Visninger . 08/09/23 administrator

Transplantation in CTCL

2 Visninger • 08/09/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Amra Osmancevic, MD, PhD, University of Gothenburg, Gothenburg, Sweden, comments on the role of allogeneic stem cell transplantation in the treatment of cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning

Transplantation for AL amyloidosis is associated with low mortality rates at a center in Brazil
00:01:23
Transplantation for AL amyloidosis is associated with low mortality rates at a center in Brazil
0 Visninger . 06/06/25 administrator
Phillip Hawkins - Amyloidosis and Benefits of Transplantation
00:14:54
Phillip Hawkins - Amyloidosis and Benefits of Transplantation
5 Visninger . 11/23/23 administrator
Outcomes of renal transplantation in patients with AL amyloidosis
00:01:20
Outcomes of renal transplantation in patients with AL amyloidosis
6 Visninger . 11/23/23 administrator
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
00:03:06
Do People of Color Have an Earlier Onset of CTCL? (Chapter 8)
3 Visninger . 08/09/23 administrator
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
00:02:51
CTCL Presentation Varies Widely Among Patients, Even Within Subtypes
3 Visninger . 08/09/23 administrator
The Importance of Collaboration in Treating CTCL (Chapter 7)
00:02:30
The Importance of Collaboration in Treating CTCL (Chapter 7)
3 Visninger . 08/09/23 administrator
The CTCL diagnosis journey
00:00:20
The CTCL diagnosis journey
7 Visninger . 08/09/23 administrator
Unmet needs for late-stage CTCL
00:01:10
Unmet needs for late-stage CTCL
3 Visninger . 08/09/23 administrator
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
00:01:16
Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visninger . 08/09/23 administrator
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
00:01:35
Swaminathan P. Iyer, MD, regarding improvements in the treatment of CTCL
4 Visninger . 08/09/23 administrator
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
00:08:49
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted
12 Visninger . 08/09/23 administrator
Pre-clinical activity of tipifarnib in CTCL
00:02:12
Pre-clinical activity of tipifarnib in CTCL
6 Visninger . 08/09/23 administrator
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
00:04:47
Cerdulatinib yields 'encouraging' results in CTCL, PTCL
4 Visninger . 08/09/23 administrator
CTCL 06 2017
02:28:08
CTCL 06 2017
2 Visninger . 08/09/23 administrator
Brentuximab vedotin for CTCL
00:02:30
Brentuximab vedotin for CTCL
2 Visninger . 08/09/23 administrator
Clonal evolution in patients with CTCL
00:02:24
Clonal evolution in patients with CTCL
4 Visninger . 08/09/23 administrator
RESMAIN: HDAC inhibitor resminostat for CTCL
00:01:23
RESMAIN: HDAC inhibitor resminostat for CTCL
3 Visninger . 08/09/23 administrator
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
00:13:18
Etiopathogenesis of CTCL for dermatology residents I Dr.P.Ram Sushruth
2 Visninger . 08/09/23 administrator
Unmet needs and upcoming therapies in CTCL
00:03:34
Unmet needs and upcoming therapies in CTCL
2 Visninger . 08/09/23 administrator